• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇与沙库巴曲缬沙坦联合缬沙坦对心肌梗死后大鼠心脏重构和功能障碍的比较和组合作用。

Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.

机构信息

Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.

Canadian Centre for Agri-Food Research in Health and Medicine, Winnipeg, MB R2H 2A6, Canada.

出版信息

Molecules. 2021 Aug 18;26(16):5006. doi: 10.3390/molecules26165006.

DOI:10.3390/molecules26165006
PMID:34443591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8401506/
Abstract

The development and progression of heart failure (HF) due to myocardial infarction (MI) is a major concern even with current optimal therapy. Resveratrol is a plant polyphenol with cardioprotective properties. Sacubitril/valsartan is known to be beneficial in chronic HF patients. In this study, we investigated the comparative and combinatorial benefits of resveratrol with sacubitril/valsartan alongside an active comparator valsartan in MI-induced male Sprague Dawley rats. MI-induced and sham-operated animals received vehicle, resveratrol, sacubitril/valsartan, valsartan alone or sacubitril/valsartan + resveratrol for 8 weeks. Echocardiography was performed at the endpoint to assess cardiac structure and function. Cardiac oxidative stress, inflammation, fibrosis, brain natriuretic peptide (BNP), creatinine and neutrophil gelatinase associated lipocalin were measured. Treatment with resveratrol, sacubitril/valsartan, valsartan and sacubitril/valsartan + resveratrol significantly prevented left ventricular (LV) dilatation and improved LV ejection fraction in MI-induced rats. All treatments also significantly reduced myocardial tissue oxidative stress, inflammation and fibrosis, as well as BNP. Treatment with the combination of sacubitril/valsartan and resveratrol did not show additive effects. In conclusion, resveratrol, sacubitril/valsartan, and valsartan significantly prevented cardiac remodeling and dysfunction in MI-induced rats. The reduction in cardiac remodeling and dysfunction in MI-induced rats was mediated by a reduction in cardiac oxidative stress, inflammation and fibrosis.

摘要

心肌梗死后心力衰竭(HF)的发展和进展即使在目前的最佳治疗下也是一个主要问题。白藜芦醇是一种具有心脏保护作用的植物多酚。已知沙库比曲缬沙坦在慢性 HF 患者中有益。在这项研究中,我们研究了白藜芦醇与沙库比曲缬沙坦联合活性对照缬沙坦在 MI 诱导的雄性 Sprague Dawley 大鼠中的比较和组合益处。MI 诱导和假手术动物接受载体、白藜芦醇、沙库比曲缬沙坦、缬沙坦单独或沙库比曲缬沙坦+白藜芦醇 8 周。在终点进行超声心动图检查以评估心脏结构和功能。测量心脏氧化应激、炎症、纤维化、脑钠肽(BNP)、肌酐和中性粒细胞明胶酶相关脂质运载蛋白。白藜芦醇、沙库比曲缬沙坦、缬沙坦和沙库比曲缬沙坦+白藜芦醇治疗可显著防止 LV 扩张并改善 MI 诱导大鼠的 LV 射血分数。所有治疗还显著降低了心肌组织氧化应激、炎症和纤维化以及 BNP。沙库比曲缬沙坦和白藜芦醇联合治疗没有显示出附加效果。总之,白藜芦醇、沙库比曲缬沙坦和缬沙坦可显著防止 MI 诱导大鼠的心脏重构和功能障碍。MI 诱导大鼠心脏重构和功能障碍的减少是通过减少心脏氧化应激、炎症和纤维化来介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/cbfe09605bf2/molecules-26-05006-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/3581f1cff307/molecules-26-05006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/ec44983527d1/molecules-26-05006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/1f3e27d2ed7c/molecules-26-05006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/aa0e97ab0dc5/molecules-26-05006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/969c0477ab79/molecules-26-05006-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/cbfe09605bf2/molecules-26-05006-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/3581f1cff307/molecules-26-05006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/ec44983527d1/molecules-26-05006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/1f3e27d2ed7c/molecules-26-05006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/aa0e97ab0dc5/molecules-26-05006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/969c0477ab79/molecules-26-05006-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/8401506/cbfe09605bf2/molecules-26-05006-g006.jpg

相似文献

1
Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.白藜芦醇与沙库巴曲缬沙坦联合缬沙坦对心肌梗死后大鼠心脏重构和功能障碍的比较和组合作用。
Molecules. 2021 Aug 18;26(16):5006. doi: 10.3390/molecules26165006.
2
Angiotensin Receptor Neprilysin Inhibitor Attenuates Myocardial Remodeling and Improves Infarct Perfusion in Experimental Heart Failure.血管紧张素受体脑啡肽酶抑制剂可减轻实验性心力衰竭中的心肌重构并改善梗死区灌注。
Sci Rep. 2019 Apr 8;9(1):5791. doi: 10.1038/s41598-019-42113-0.
3
Effects of sacubitril-valsartan on aging-related cardiac dysfunction.沙库巴曲缬沙坦对与衰老相关的心脏功能障碍的影响。
Eur J Pharmacol. 2024 Sep 5;978:176794. doi: 10.1016/j.ejphar.2024.176794. Epub 2024 Jul 3.
4
Sacubitril/valsartan ameliorates cardiac function and ventricular remodeling in CHF rats via the inhibition of the tryptophan/kynurenine metabolism and inflammation.沙库巴曲缬沙坦通过抑制色氨酸/犬尿氨酸代谢和炎症改善心衰大鼠的心功能和心室重构。
Sci Rep. 2024 May 29;14(1):12377. doi: 10.1038/s41598-024-62472-7.
5
Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts.早期应用沙库巴曲缬沙坦对压力超负荷大鼠心脏的心脏保护作用。
Sci Rep. 2021 Aug 16;11(1):16542. doi: 10.1038/s41598-021-95988-3.
6
Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction.沙库巴曲缬沙坦对异丙肾上腺素诱导的左心室功能障碍小鼠模型重塑、纤维化和线粒体的影响。
Int J Cardiol. 2024 Aug 15;409:132203. doi: 10.1016/j.ijcard.2024.132203. Epub 2024 May 23.
7
LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model.LCZ696 治疗可降低心肌梗死后心力衰竭大鼠模型的室性心律失常诱导性。
Cardiovasc Ther. 2019 Jul 1;2019:6032631. doi: 10.1155/2019/6032631. eCollection 2019.
8
Sacubitril/Valsartan Improves Cardiac Function and Decreases Myocardial Fibrosis Via Downregulation of Exosomal miR-181a in a Rodent Chronic Myocardial Infarction Model.沙库巴曲缬沙坦通过下调鼠慢性心肌梗死模型中细胞外囊泡 miR-181a 改善心功能和减少心肌纤维化。
J Am Heart Assoc. 2020 Jul 7;9(13):e015640. doi: 10.1161/JAHA.119.015640. Epub 2020 Jun 15.
9
Antiarrhythmic and Anti-Inflammatory Effects of Sacubitril/Valsartan on Post-Myocardial Infarction Scar.沙库巴曲缬沙坦对心肌梗死后瘢痕的抗心律失常和抗炎作用。
Circ Arrhythm Electrophysiol. 2024 May;17(5):e012517. doi: 10.1161/CIRCEP.123.012517. Epub 2024 Apr 26.
10
Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure.沙库巴曲缬沙坦的协同作用可改善心力衰竭大鼠的血液动力学、抗纤维化和运动耐量。
Am J Physiol Heart Circ Physiol. 2019 Feb 1;316(2):H289-H297. doi: 10.1152/ajpheart.00579.2018. Epub 2018 Nov 21.

引用本文的文献

1
Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology.中药复方通过调节信号通路改善心脏相关病理状况。
Front Pharmacol. 2025 Apr 2;16:1499060. doi: 10.3389/fphar.2025.1499060. eCollection 2025.
2
Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes.沙库巴曲缬沙坦联合用药部分通过改善 2 型糖尿病大鼠的β-AR 反应性来改善心脏收缩功能,但不改善舒张功能。
Int J Mol Sci. 2024 Oct 2;25(19):10617. doi: 10.3390/ijms251910617.
3
Assessing the early prognosis of heart failure after acute myocardial infarction using left ventricular pressure-strain loop: a prospective randomized controlled clinical study.

本文引用的文献

1
Sacubitril/Valsartan Improves Cardiac Function and Decreases Myocardial Fibrosis Via Downregulation of Exosomal miR-181a in a Rodent Chronic Myocardial Infarction Model.沙库巴曲缬沙坦通过下调鼠慢性心肌梗死模型中细胞外囊泡 miR-181a 改善心功能和减少心肌纤维化。
J Am Heart Assoc. 2020 Jul 7;9(13):e015640. doi: 10.1161/JAHA.119.015640. Epub 2020 Jun 15.
2
Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts.沙库巴曲缬沙坦通过恢复心肌成纤维细胞中 PKG 信号转导减少左心室压力超负荷所致的心肌纤维化。
Circ Heart Fail. 2019 Apr;12(4):e005565. doi: 10.1161/CIRCHEARTFAILURE.118.005565.
3
利用左心室压力-应变环评估急性心肌梗死后心力衰竭的早期预后:一项前瞻性随机对照临床研究。
Quant Imaging Med Surg. 2024 Feb 1;14(2):1957-1970. doi: 10.21037/qims-23-1079. Epub 2024 Jan 23.
4
Immunomodulation and immunopharmacology in heart failure.心力衰竭的免疫调节和免疫药理学。
Nat Rev Cardiol. 2024 Feb;21(2):119-149. doi: 10.1038/s41569-023-00919-6. Epub 2023 Sep 14.
5
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention.心肌梗死后纤维化:病理生理学、检查与干预
Front Pharmacol. 2023 Mar 28;14:1070973. doi: 10.3389/fphar.2023.1070973. eCollection 2023.
6
Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity.中性肽链内切酶抑制在预防蒽环类药物所致心脏毒性中的作用
Cancers (Basel). 2023 Jan 3;15(1):312. doi: 10.3390/cancers15010312.
7
Oxidative Stress as a Therapeutic Target of Cardiac Remodeling.氧化应激作为心脏重塑的治疗靶点
Antioxidants (Basel). 2022 Nov 30;11(12):2371. doi: 10.3390/antiox11122371.
8
Resveratrol alleviates Ang II-induced vascular smooth muscle cell senescence by upregulating E2F1/SOD2 axis.白藜芦醇通过上调E2F1/SOD2轴减轻血管紧张素II诱导的血管平滑肌细胞衰老。
Toxicol Res (Camb). 2022 Sep 3;11(5):831-840. doi: 10.1093/toxres/tfac051. eCollection 2022 Oct.
9
Role of resveratrol in inhibiting pathological cardiac remodeling.白藜芦醇在抑制病理性心脏重塑中的作用。
Front Pharmacol. 2022 Sep 1;13:924473. doi: 10.3389/fphar.2022.924473. eCollection 2022.
10
Effects of Valsartan on LN, FN, MDA, Renal Tissue Fibrosis, and Inflammatory Infiltration in DN Rats.缬沙坦对糖尿病肾病大鼠 LN、FN、MDA、肾组织纤维化及炎症浸润的影响。
Contrast Media Mol Imaging. 2022 Aug 4;2022:6473393. doi: 10.1155/2022/6473393. eCollection 2022.
Resveratrol Inhibits the TGF-1-Induced Proliferation of Cardiac Fibroblasts and Collagen Secretion by Downregulating miR-17 in Rat.
白藜芦醇通过下调 miR-17 抑制 TGF-β1 诱导的大鼠心肌成纤维细胞增殖和胶原分泌。
Biomed Res Int. 2018 Dec 17;2018:8730593. doi: 10.1155/2018/8730593. eCollection 2018.
4
Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits.沙库巴曲缬沙坦可预防兔心肌梗死后心室重构和保持收缩功能。
J Am Coll Cardiol. 2018 Nov 6;72(19):2342-2356. doi: 10.1016/j.jacc.2018.07.102.
5
Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites.白藜芦醇通过抑制心脏毒性 HETE 代谢物改善 MI 诱导的心力衰竭的心脏功能和运动表现。
J Mol Cell Cardiol. 2018 Dec;125:162-173. doi: 10.1016/j.yjmcc.2018.10.023. Epub 2018 Oct 28.
6
Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction.LCZ696(沙库巴曲/缬沙坦)对实验性急性心肌梗死后的心脏保护作用
JACC Basic Transl Sci. 2017 Dec 25;2(6):655-668. doi: 10.1016/j.jacbts.2017.08.001. eCollection 2017 Dec.
7
Left ventricular ejection fraction reassessment post-myocardial infarction: Current clinical practice and determinants of adverse remodeling.心肌梗死后左心室射血分数再评估:当前的临床实践和不良重构的决定因素。
Am Heart J. 2018 Apr;198:91-96. doi: 10.1016/j.ahj.2017.11.014. Epub 2017 Dec 5.
8
Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients.沙库巴曲缬沙坦在射血分数降低的心力衰竭患者中实现了射血分数改善和逆向重构。
Am J Cardiovasc Dis. 2017 Dec 20;7(6):108-113. eCollection 2017.
9
Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model.白藜芦醇对心肌梗死后心力衰竭模型的心脏保护作用。
Oxid Med Cell Longev. 2017;2017:6819281. doi: 10.1155/2017/6819281. Epub 2017 Oct 3.
10
Effects of cyanidin 3-0-glucoside on cardiac structure and function in an animal model of myocardial infarction.矢车菊素 3-O-葡萄糖苷对心肌梗死动物模型心脏结构和功能的影响。
Food Funct. 2017 Nov 15;8(11):4089-4099. doi: 10.1039/c7fo00709d.